Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Iatrogenic rheumatic diseases].

Pierre-Alain Buchard1

  • 1Service ambulatoire, Clinique romande de réadaptation, Sion.

Revue Medicale De La Suisse Romande
|November 24, 2004
PubMed
Summary

This review highlights five rheumatic diseases linked to common drug treatments, including statins and gout. Reporting adverse drug reactions is crucial for improving patient health and medical knowledge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Non-steroidal anti-inflammatory drugs : clarification for the practitioner].

Revue medicale suisse·2022
Same author

Complex regional pain syndrome and bone marrow oedema syndrome: family ties potentially closer than expected.

BMJ case reports·2020
Same author

[Complex regional pain syndrome].

Revue medicale suisse·2019
Same author

Revue medicale suisse·2019
Same author

[Adhesive capsulitis of the shoulder : Update 2017].

Revue medicale suisse·2017
Same author

[When should a patient with low back pain/sciatica be referred to the emergency ward?].

Revue medicale suisse·2010

Area of Science:

  • Rheumatology
  • Pharmacology
  • Clinical Medicine

Background:

  • Drug-induced rheumatic conditions are uncommon but clinically significant.
  • Understanding these associations is vital for patient safety and effective treatment.

Observation:

  • Case reviews illustrate associations between specific drugs and rheumatic conditions: statins (myopathy), quinolones (tendinopathy), viscosupplementation (pseudoseptic arthritis), diuretics (gout), and barbiturates (adhesive capsulitis).

Findings:

  • The rarity of these drug-associated rheumatic diseases limits the availability of evidence-based therapeutic recommendations.
  • Illustrative cases underscore the need for heightened clinical awareness.

Implications:

  • Reporting adverse drug reactions to regulatory systems is essential for accumulating knowledge on rare drug-induced rheumatic diseases.
  • Enhanced reporting can improve public health by informing clinical practice and drug safety guidelines.

Related Experiment Videos